Table 3 Clinical characteristics of target patients with AAD
Characteristics | Reports, n (%) |
|---|---|
Patient age(year) | |
  < 18 | 231 (4.28%) |
 18–64 | 1867 (34.59%) |
  ≥ 65 | 2332 (43.21%) |
 Unkown | 967 (17.92%) |
Patient gender | |
 Male | 1989 (36.85%) |
 Female | 2779 (51.49%) |
 Unkown | 629 (11.65%) |
Reporter | |
 Consumer | 1054 (19.53%) |
 Lawyer | 14 (0.26%) |
 Other health-professional | 1213 (22.48%) |
 Pharmacist | 885 (16.40%) |
 Physician | 1701 (31.52%) |
 Unkown | 530 (9.82%) |
Continent | |
 Africa | 25 (0.46%) |
 Asian | 329 (6.10%) |
 Europe | 2026 (37.54%) |
 North America | 2610 (48.36%) |
 Oceania | 18 (0.33%) |
 South America | 49 (0.91) |
 Unkown | 340 (6.30%) |
Year | |
 2004 | 207 (3.84%) |
 2005 | 210 (3.89%) |
 2006 | 231 (4.28%) |
 2007 | 206 (3.82%) |
 2008 | 266 (4.93%) |
 2009 | 294 (5.45%) |
 2010 | 224 (4.15%) |
 2011 | 205 (3.80%) |
 2012 | 172 (3.19%) |
 2013 | 352 (6.52%) |
 2014 | 294 (5.45%) |
 2015 | 324 (6.00%) |
 2016 | 306 (5.67%) |
 2017 | 313 (5.80%) |
 2018 | 352 (6.52%) |
 2019 | 440 (8.15%) |
 2020 | 322 (5.97%) |
 2021 | 414 (7.67%) |
 2022 | 265 (4.91%) |